SEC Form 4 · accession 0001171843-16-010658
IMMUNOMEDICS INC · IMMU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cynthia L Goldenberg
Officer — President and CEO · Director
Period of report
Jun 10, 2016
Accepted (ET)
Jun 14, 2016 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000722830
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 10, 2016 | M | 11,326 | $2.63 | A | 650,396 | D | |
| Common StockF2,F3,F1 | Jun 10, 2016 | S | 11,326 | $3.0709 | D | 639,070 | D | |
| Common StockF4 | Jun 10, 2016 | M | 81,990 | $2.50 | A | 5,317,452 | I | See footnote |
| Common StockF4 | Jun 10, 2016 | M | 10,050 | $2.63 | A | 5,327,502 | I | See footnote |
| Common StockF5,F6,F4 | Jun 10, 2016 | S | 92,040 | $3.0547 | D | 5,235,462 | I | See footnote |
| Common StockF1 | Jun 13, 2016 | M | 128,674 | $2.63 | A | 767,744 | D | |
| Common StockF3,F7,F1 | Jun 13, 2016 | S | 128,674 | $3.0247 | D | 639,070 | D | |
| Common StockF4 | Jun 13, 2016 | M | 139,950 | $2.63 | A | 5,375,412 | I | See footnote |
| Common StockF5,F8,F4 | Jun 13, 2016 | S | 139,950 | $3.0198 | D | 5,235,462 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F9 | $2.63 | Jun 10, 2016 | M | 11,326 | D | — | Jun 14, 2016 | Common Stock, par value $0.01 per share | 11,326 | 128,674 | D |
| Stock Option (right to buy)F11,F10 | $2.50 | Jun 10, 2016 | M | 81,990 | D | — | Jun 10, 2016 | Common Stock, par value $0.01 per share | 81,990 | 0 | I |
| Stock Option (right to buy)F12,F9 | $2.63 | Jun 10, 2016 | M | 10,050 | D | — | Jun 14, 2016 | Common Stock, par value $0.01 per share | 10,050 | 139,950 | I |
| Stock Option (right to buy)F9 | $2.63 | Jun 13, 2016 | M | 128,674 | D | — | Jun 14, 2016 | Common Stock, par value $0.01 per share | 128,674 | 0 | D |
| Stock Option (right to buy)F12,F9 | $2.63 | Jun 13, 2016 | M | 139,950 | D | — | Jun 14, 2016 | Common Stock, par value $0.01 per share | 139,950 | 0 | I |
Explanation of responses
- F1Includes a total of 190,000 shares held as joint tenants by the reporting person and her spouse, David M. Goldenberg, the Issuer's Chief Scientific Officer, Chief Patent Officer and Chairman of the Board of Directors.
- F10These stock options were granted pursuant to the Issuer's 2006 Stock Incentive Plan, and vested 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter.
- F11The reporting person's spouse was granted these stock options pursuant to the Issuer's 2006 Stock Incentive Plan.
- F12The reporting person's spouse was granted these stock options pursuant to the Issuer's 2002 Stock Incentive Plan.
- F2The price in column 4 is a weighted average price. The prices actually received in this transaction range from $3.07 to $3.08.
- F3The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
- F4Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interests therein.
- F5The reporting person's spouse has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
- F6The price in column 4 is a weighted average price. The prices actually received in this transaction range from $3.04 to $3.085.
- F7The price in column 4 is a weighted average price. The prices actually received in this transaction range from $3.00 to $3.12.
- F8The price in column 4 is a weighted average price. The prices actually received in this transaction range from $2.96 to $3.12.
- F9These stock options were granted pursuant to the Issuer's 2002 Stock Option Plan, and vested over four years at a rate of 25% per year.